View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
MONDAY, March 19 (HealthDay News) -- Prenatal methamphetamine (MA) exposure is linked to emotional and anxiety problems in 3-year-olds and an increased risk of attention-deficit/hyperactivity disorder (ADHD) in 5-year-olds, according to a study published online March 19 in Pediatrics.
Linda L. LaGasse, Ph.D., of Brown University in Providence, R.I., and colleagues analyzed data from the Infant Development, Environment, and Lifestyle study, a prospective, longitudinal study of prenatal MA exposure and child outcome. Prenatal exposure was determined by maternal self-report and/or meconium results. Exposed and comparison groups were matched by race, birth weight, public health insurance, and education; both groups had prenatal exposures to tobacco, alcohol, or marijuana. Using the caregiver report on the Child Behavior Checklist at ages 3 and 5 years, 330 children (166 exposed and 164 controls) were assessed for behavior problems.
The researchers found that MA exposure was associated with higher scores, reflecting increased emotional reactivity and anxious/depressed problems at both ages and externalizing and ADHD problems by 5 years of age. Heavy exposure was related to attention problems and withdrawn behavior at both ages. There were no effects for MA seen on the scales for internalizing or total behavior problems.
"This first report of behavior problems in patients as young as 3 years associated with MA exposure identifies an important public health problem," the authors write.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top